Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025)
Roivant Sciences (ROIV) posted Interest & Investment Income of $136.9 million for Q4 2025, up 5205.27% on a QoQ basis from $2.6 million in Q3 2025, and down 32.8% year-over-year from $203.8 million in Q4 2024.
Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025) Analysis & Trends
Roivant Sciences' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $136.9 million for Q4 2025.
- Quarterly Interest & Investment Income fell 32.8% year-over-year to $136.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $343.7 million (down 15.88% YoY) and the FY2026 annual result came in at $178.1 million, down 31.07% from the prior year.
- Interest & Investment Income was $136.9 million for Q4 2025 at Roivant Sciences, up from $2.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $203.8 million in Q4 2024 and bottomed at $62000.0 in Q3 2021.
- A 5-year average of $43.2 million and a median of $15.5 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 9045.16% — and 2025, when it tumbled 99.35%.
- Roivant Sciences' Interest & Investment Income stood at $199000.0 in 2021, then surged by 8894.97% to $17.9 million in 2022, then soared by 251.77% to $63.0 million in 2023, then soared by 223.58% to $203.8 million in 2024, then sank by 32.8% to $136.9 million in 2025.
- Business Quant data shows ROIV's Interest & Investment Income at $136.9 million in Q4 2025, $2.6 million in Q3 2025, and $470000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Roivant Sciences | 24.27 Bn | 24.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136.93 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 470,000.00 |
| Dec 31, 2024 | 203.75 Mn |
| Sep 30, 2024 | 69.77 Mn |
| Jun 30, 2024 | 72.13 Mn |
| Dec 31, 2023 | 62.97 Mn |
| Sep 30, 2023 | 14.30 Mn |
| Jun 30, 2023 | 16.72 Mn |
| Dec 31, 2022 | 17.90 Mn |
| Sep 30, 2022 | 5.67 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Dec 31, 2021 | 199,000.00 |
| Sep 30, 2021 | 62,000.00 |